Dr. Gulati is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5 E 98th St
Fl 5
New York, NY 10029Phone+1 212-241-9728
Education & Training
New York University School of MedicinePost-Doctoral Fellowship, 2020 - 2021- NYU Grossman School of MedicineResidency, Dermatology, 2018 - 2021
Memorial Sloan Kettering Cancer CenterInternship, Transitional Year, 2017 - 2018
Weill Cornell MedicineClass of 2017, MD
Rockefeller UniversityPhD, Biological Sciences, 2016- Columbia UniversityBA, 2008
Certifications & Licensure
NY State Medical License 2021 - 2026- American Board of Dermatology Dermatology
Publications & Presentations
PubMed
- 50 citationsGene expression profiling of the leading edge of cutaneous squamous cell carcinoma: IL-24-driven MMP-7.Hiroshi Mitsui, Mayte Suárez-Fariñas, Nicholas Gulati, Kejal R. Shah, Maria Vittoria Cannizzaro
The Journal of Investigative Dermatology. 2014-05-01 - 10 citationsNo association between dupilumab use and short-term cancer development in atopic dermatitis patients.Shayan Owji, Benjamin Ungar, Danielle P Dubin, Dina Poplausky, Jade N Young
The Journal of Allergy and Clinical Immunology. in Practice. 2023-05-01 - 59 citationsBiomarkers of alopecia areata disease activity and response to corticosteroid treatmentJudilyn Fuentes-Duculan, Nicholas Gulati, Kathleen M. Bonifacio, Norma Kunjravia, Xiuzhong Zheng
Experimental Dermatology. 2016-04-01
Press Mentions
Symptoms Resolve with Dupilumab in Patients with Drug ReactionsAugust 31st, 2023- Melanoma Is Overdiagnosed at ‘Alarming’ Rates. Here’s What to KnowFebruary 15th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
